Table 2.
Clinical characteristics of donor cohort
| Donors without diabetes (n = 16) | Donors with diabetes (n = 72) | P-value | |
|---|---|---|---|
| Age, years | 28.1 ± 5.4 | 30.6 ± 11.6 | 0.874 |
| Female/male (% female) | 11/5 (68.8%) | 44/28 (60.3%) | 0.776 |
| BMI (kg/m2) | 23 ± 4.6 | 27 ± 5.4 | 0.006 (*) |
| Ethnicity, % caucasian | 68.8% | 83.6% | 0.157 |
| HbA1c (%) | 5.2 ± 0.3 | 8.4 ± 1.7 | < 0.0001 (*) |
| T1DM/T2DM (% T1DM) | N/A | 66/6 (90.4%) | N/A |
| Insulin treatment | N/A | 66/6 (90.4%) | NA |
| Duration of diabetes (years) | N/A | 14.8 ± 7.2 | N/A |
| Non-steroidal anti-inflammatory drug (NSAID) use (% use) | 0/16 (0%) | 4/68 (5.5%) | > 0.999 |
Values are mean ± SD unless otherwise indicated
T1DM, Type 1 Diabetes mellitus; T2DM, Type 2 Diabetes mellitus; BMI, Body mass index
Significant P values indicated by an asterisk (*)